Clover May

Clover is an associate in the Emerging Companies and M&A team in London. She specialises in advising companies and investors in the technology and life science sectors on venture capital investments, M&A transactions and general corporate matters.

最新新闻和观点

View Clover's insights

点击此处了解更多

酒店与休闲

Advising on Tropic Biosciences' US$105 million Series C financing

2026年3月25日

作者

就业、养老金和流动性

New legislation governing Allocation of Tips to come into force in July 2024

2024年3月21日

Quick read

作者 Clover May

点击此处了解更多

员工激励

Lexology Executive Compensation & Employee Benefits 2023 - UK chapter

2023年11月14日

作者

点击此处了解更多

Clover May

专长

执业领域和服务团队

行业

最新新闻和观点

Advising on Tropic Biosciences' US$105 million Series C financing

Clover May

专长

执业领域和服务团队

行业

最新新闻和观点

Advising on Tropic Biosciences' US$105 million Series C financing

Related news & insights

The EU Digital Omnibus on AI – What the political deal means

Cabinet decision on the Statutory Health Insurance Contribution Stabilization Act – Financial burdens on German pharmaceutical companies

Federal Administrative Court on the Delineation between Substance-Based Medical Devices and Medicinal Products

CJEU Advocate General on Distributors’ Obligations for Medical Devices

Investing in the German Tax Advisory Market: New Rules of the Game Following the 9th StBerG Amendment

Taylor Wessing advises CLS Holdings plc on the sale of “The Brix” in Essen

Federal Court of Justice Ruling on Public Advertising for Medical Cannabis on Online Platforms

Law Against Digital Violence – New Obligations for Online Service Providers

Industrial Land Reform in China: Expanded Rural Land Market Access and Shortened Land Use Terms

#7: State of the EU Crypto Industry: MiCA, Tokenisation and What Comes Next

相关人员

与我会面：